- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 57.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 57.28M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 55.38M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $15.86M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $56.13M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $40.27M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $52.93M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $59.02M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $33.81M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $46.12M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.49M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.87M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.09M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.9M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $57.61M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $67.29M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $59.02M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $68.92M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.25 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.89M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $6.82M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.91M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $13.61M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$7.2M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$13.87M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$7.54M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$14.73M |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $12K |